Moreover, a role of MUL1 in the degradation of MFN2 was suggested in the context of dopaminergic (DA) neuronal loss (Tang et al., 2015), closely related to Parkinson’s and Alzheimer’s diseases. The gene discussed is MFN2; the disease is early-onset autosomal dominant Alzheimer disease.